Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1880

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 1880
---
s from January 2024 Offering 
     1,898,296  
     - 
  
    Proceeds from IPO and Over-Allotment, net of underwriting discounts, commissions, and deferred offering costs paid in 2023 of $1,198,111 
     -  
     6,303,905 
  
    Proceeds from ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 
     1,729,810  
     - 
  
    Proceeds from Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600 
     3,414,502  
     - 
  
    Proceeds from Exercise of Warrants 
     -  
     1,131,771 
  
    Proceeds from Exercise of Pre-Funded Warrants 
     10,963  
     - 
  
    Proceeds from Notes Payable 
     -  
     650,000 
  
    Repayment of Notes Payable 
     -  
     (1,611,111)
  
    Proceeds from Advances - Related Party 
     -  
     250,000 
  
    Repayment of Related Party Advances 
     -  
     (250,000)
  
    Net Cash Provided by Financing Activities 
     7,053,571  
     6,474,565 

    Effect of Exchange Rate Changes on Cash 
     499  
     61,853 

    Change in Cash and Cash Equivalents 
     (483,132) 
     1,877,620 
  
    Cash and Cash Equivalents—Beginning of Period 
     2,142,485  
     264,865 
  
    Cash and Cash Equivalents—End of Period 
    $1,659,353  
    $2,142,485 

    SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION 

    Cash paid During the Year for Interest 
    $8,772  
    $179,117 
  
    Cash paid During the Year for Income Taxes 
    $2,000  
    $1,000 

    NONCASH INVESTING/FINANCING ACTIVITIES 

    Conversion of Debt into Common Stock 
    $-  
    $7,989,598